Sundquist, E., Kauppila, J. H., Veijola, J., Mroueh, R., Lehenkari, P., Laitinen, S., . . . Salo, T. (2017). Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups. British Journal of Cancer, 116(5), 640. https://doi.org/10.1038/bjc.2016.455
Chicago Style (17th ed.) CitationSundquist, Elias, et al. "Tenascin-C and Fibronectin Expression Divide Early Stage Tongue Cancer into Low- and High-risk Groups." British Journal of Cancer 116, no. 5 (2017): 640. https://doi.org/10.1038/bjc.2016.455.
MLA (9th ed.) CitationSundquist, Elias, et al. "Tenascin-C and Fibronectin Expression Divide Early Stage Tongue Cancer into Low- and High-risk Groups." British Journal of Cancer, vol. 116, no. 5, 2017, p. 640, https://doi.org/10.1038/bjc.2016.455.